Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Fam Pract ; 20(4): 420-4, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12876114

ABSTRACT

OBJECTIVE: This paper describes the characteristics of Belgian people who declare that they have a personal GP (PGP) compared with those who do not. Furthermore, patterns of cardiovascular prevention and care are described for these two groups. METHODS: The data are derived from the 1997 Belgian Health Interview Survey (HIS) in which a representative sample (n = 10 221) of the Belgian population was questioned. The HIS data about physical activity, food, blood pressure, cholesterol, cardiovascular diseases, diabetes and stroke are analysed. RESULTS: After standardization for age and gender, 7.0% of the subjects declared that they did not have a PGP. The mean age of patients without a PGP (33.2 +/- 20.4 years) is significantly lower than for those with a PGP (40.4 +/- 22.7 years) (P < 0.001). More smokers (38.5% compared with 28.5%) were reported among the subjects without a PGP (P < 0.001). For 14.8% of the subjects without a PGP, their blood pressure had never been measured, and for 51.1% their cholesterol had never been measured (6.7% and 35.7%, respectively in subjects with a PGP). Among the subjects without a PGP, 3.8% had high blood pressure and 1.5% had a coronary heart disease. Among the hypertensive patients without a PGP, 43.6% are not treated by any physician. CONCLUSION: Subjects without a PGP were less likely to have a healthy way of life. Having a PGP seemed to have a beneficial influence on the screening for and the follow-up of cardiovascular risk factors. However, it has never been confirmed that providing people who do not have a PGP with one would result in health improvements. In particular, cardiac patients without a PGP sought their medical treatment directly from specialists.


Subject(s)
Cardiovascular Diseases/prevention & control , Cardiovascular Diseases/therapy , Continuity of Patient Care , Family Practice , Patient Acceptance of Health Care , Preventive Health Services/statistics & numerical data , Adolescent , Adult , Belgium , Child , Child, Preschool , Female , Follow-Up Studies , Health Behavior , Health Care Surveys , Humans , Infant , Infant, Newborn , Male , Middle Aged , Risk Factors
2.
Int J Clin Pract ; 57(5): 430-4, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12846351

ABSTRACT

The aim of this study was to screen a target population for modifiable cardiovascular risk factors and to find out how treatment goals were achieved in the treated population. All inhabitants aged between 45 and 64 years in the town of Lede in Belgium were invited by the local authorities for a free health check-up. In total, 629 subjects were screened. Total cholesterol > or = 250 mg/dl or triglycerides > or = 200 mg/dl was found in 38%, increased fasting glucose (> or = 110 mg/dl) in 8.6%, diabetes in 2.8%, increased systolic blood pressure (SBP) (> or = 140 mmHg) in 22% and increased diastolic blood pressure (DBP) (> or = 90 mmHg) in 8%. The low-density lipoprotein cholesterol (LDL-C) target level of 115 mg/dl was attained in 13% of treated women and 34% of treated men. Target levels for SBP and DBP were attained in 40% and 75% respectively of those treated. Fasting glucose < 120 mg/dl was found in 33% of the diabetic participants.


Subject(s)
Cardiovascular Diseases/prevention & control , Belgium , Blood Pressure , Cholesterol/blood , Diabetic Angiopathies/prevention & control , Female , Humans , Hyperlipidemias/complications , Hypertension/complications , Male , Mass Screening/methods , Middle Aged , Obesity/complications , Smoking/adverse effects , Triglycerides/blood
3.
Cardiology ; 97(4): 230-2, 2002.
Article in English | MEDLINE | ID: mdl-12145480

ABSTRACT

We report the case of a man whose high-density lipoprotein cholesterol (HDL-C) and the ratios of total cholesterol to HDL-C and low-density lipoprotein cholesterol to HDL-C worsened dramatically during pravastatin treatment. After 3 years, pravastatin was replaced by fenofibrate. The result was spectacular. The HDL-C increased to at least twice the level obtained during pravastatin.


Subject(s)
Anticholesteremic Agents/adverse effects , Pravastatin/adverse effects , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Humans , Hypercholesterolemia/drug therapy , Male , Middle Aged , Treatment Failure
SELECTION OF CITATIONS
SEARCH DETAIL
...